Black Rock Inc. Cocrystal Pharma, Inc. Transaction History

Black Rock Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.38 - $0.55 $84,461 - $122,246	-222,266 Reduced 20.01%	888,742 $364,000
Q1 2022 May 12, 2022	SELL	$0.48 - $0.71 $6,041 - $8,936	-12,586 Reduced 1.12%	1,111,008 $611,000
Q4 2021 Feb 10, 2022	BUY	$0.65 - $1.02 $6,388 - $10,025	9,829 Added 0.88%	1,123,594 $730,000
Q3 2021 Nov 09, 2021	SELL	$1.01 - $1.25 $24,306 - $30,082	-24,066 Reduced 2.12%	1,113,765 $1.17 Million
Q2 2021 Aug 11, 2021	BUY	$1.08 - $2.14 $1.23 Million - $2.43 Million	1,137,831 New	1,137,831 $1.42 Million

Ticker COCP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,122,420
Market Cap $21.3M
Description
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.